Bryan Edwards, MD, senior vice president of Winston-Salem, N.C.-based Novant Health Orthopedics & Sports Medicine, and David Homesley, MD, chief of total joint replacement at Novant Health, discuss the big trends and opportunities for artificial intelligence and robotics in orthopedics…
The Latest
As an orthopedic surgeon, I always strive to help my patients understand that healthcare is a two-way street. Even if I do my best work and the surgical procedure goes without a hitch, outcomes can be highly variable, and the…
Steven R. Garfin, MD, is a board-certified orthopedic spine surgeon at UC San Diego Health.
Here are the top 10 most-read articles on Becker's Spine Review from Feb. 25-March 1.
A study in Spine analyzed trends in U.S. lumbar fusion rates and associated costs by surgical indication.
Patients obtain their expectations for lumbar surgery from multiple sources, according to a study in Spine.
MedTech Outlook Solution named Mighty Oak Medical its Provider of the Year for 2019.
The FDA granted OrthoGrid Systems' PhantomMSK Orthopedic Platform 510(k) clearance.
Aesculap Biologics achieved 50 percent enrollment in its ongoing phase 3 clinical trial of Novocart 3D, an autologous chondrocyte transplantation system designed to treat articular cartilage defects of the knee.
The global autologous matrix-induced chondrogenesis market is expected to grow at an 8.6 percent compound annual growth rate by 2024, according to a Persistence Market Research report.